Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01168
|
|||||
| Drug Name |
Sulpiride
|
|||||
| Synonyms |
(+/-)-Sulpiride; (RS)-(+/-)-sulpiride; (inverted question mark)-Sulpiride; Abilit; Aiglonyl; Alimoral; Allphar Brand of Sulpiride; Almirall Brand of Sulpiride; Areu Brand of Sulpiride; Arminol; Bosnyl (TN); Calmoflorine; Centrum Brand of Sulpiride; Championyl; Coolspan; Darleton; Deponerton; Desisulpid; Desitin Brand of Sulpiride; Desmenat; Digton; Dobren; Dogmatil; Dogmatil (TN); Dogmatyl; Dogmatyl (TN); Dolmatil; Dolorgiet Brand of Sulpiride; Dresent; Eglonil; Eglonyl; Eglonyl (TN); Ekilid; Enimon; Equilid; Erempharma Brand of Sulpiride; Eusulpid; Fardalan; Fidelan; Fumouzer Brand of Sulpiride; Guastil; Hennig Brand of Sulpiride; Hexal Brand of Sulpiride; Hoechst Brand of Sulpiride; Hormosan Brand of Sulpiride; Isnamide; Krewel Brand of Sulpiride; Kylistro; Lebopride; Levobren; Levopraid; Levosulpirida; Levosulpirida [INN-Spanish]; Levosulpiride [INN]; Levosulpiridum; Levosulpiridum [INN-Latin]; Lisopiride; Magnetic resonance imaging sulpiride; Mariastel; Meresa; Meresa (TN); Miradol; Mirbanil; Misulvan; N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide; Neogama; Neuraxpharm (TN); Norestran; Normum; Nufarol; Omiryl; Omperan; Ozoderpin; Pharmacia Brand of Sulpiride; Pontiride; Psicocen; Psicofarma Brand of Sulpiride; Pyrikappl; Pyrkappl; R. D. 1403; R.D. 1403; RD 1403; RV-12309; Ratiopharm (TN); Restful; Rosemont Brand of Sulpiride; S 8010; Sanofi Synthelabo Brand of Sulpiride; Sanofi-Synthelabo Brand of Sulpiride; Sernevin; Splotin; Spyfarma Brand of Sulpiride; Stamonevrol; Sulp; Sulperide; Sulpirid; Sulpirid (TN); Sulpirida; Sulpirida [INN-Spanish]; Sulpiride (JP15/USAN/INN); Sulpiride [USAN:INN:BAN:JAN]; Sulpiridum; Sulpiridum [INN-Latin]; Sulpiryd (TN); Sulpitil; Sulpivert; Sulpor; Sulpride; Sulpyrid; Suprium; Sursumid; Synedil; Tepavil; Uriach Brand of Sulpiride; Valirem; Vertigo Meresa; Vertigo neogama; Vertigo-Meresa; Vertigo-neogama; Zemorcon
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Schizophrenia [ICD11:6A20] | Approved | [1] | |||
| Therapeutic Class |
Antipsychotic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H23N3O4S
|
|||||
| Canonical SMILES |
CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC
|
|||||
| InChI |
InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)/t11-/m0/s1
|
|||||
| InChIKey |
BGRJTUBHPOOWDU-NSHDSACASA-N
|
|||||
| CAS Number |
CAS 15676-16-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 341.4 | Topological Polar Surface Area | 110 | ||
| Heavy Atom Count | 23 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
0.6
|
|||||
| PubChem CID | ||||||
| PubChem SID |
109891217
,11112626
,11113767
,118307513
,118499642
,12013945
,121361944
,124658852
,124800326
,125240941
,125312446
,126631916
,127513099
,131279812
,131342348
,14753743
,17405645
,24278709
,24860759
,26719874
,26751950
,26751951
,44872150
,46386685
,47217076
,47365485
,47440570
,47515605
,47811047
,48185264
,48259530
,48334802
,49681723
,49831917
,50104627
,50104628
,51091649
,53778195
,56311627
,57408562
,57649005
,75714399
,85788354
,90340908
,91693560
,92303410
,92308238
,92308760
,92710402
,9286574
|
|||||
| ChEBI ID |
CHEBI:64119
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | PEPT1 | Transporter Info | Peptide transporter 1 | Substrate | [2] | |
| References | ||||||
| 1 | Wockhardt Ltd.: Sulpiride Tablets | |||||
| 2 | Studies on intestinal absorption of sulpiride (2): transepithelial transport of sulpiride across the human intestinal cell line Caco-2. Biol Pharm Bull. 2002 Oct;25(10):1345-50. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.